Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florent Grange

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
ESMO Open|November 28, 2017
Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signatureJean-Jacques Grob, Laurent Mortier, Lionel D'Hondt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 24, 2025
Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomasDamien Sanogo, Romain Levard, Julie Cassecuel, et al.
Archives of Dermatology|September 19, 2012
Clinical and sociodemographic characteristics associated with thick melanomas. A population-based, case-case study in FranceFlorent Grange, Coralie Barbe, Francois Aubin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 29, 2026
Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS)Théo Erard, Gaelle Quéreux, Mona Amini-Adle, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|January 29, 2011
Sentinel lymph node biopsy or nodal observation in melanoma: a prospective study of patient choicesFlorent Grange, Eve Maubec, Coralie Barbe, et al.
JAMA Dermatology|August 16, 2013
Distinctive features of melanoma and its management in elderly patients: a population-based study in FranceDragos Ciocan, Coralie Barbe, Francois Aubin, et al.
The American Journal of Surgical Pathology|December 10, 2015
Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the ScalpSebastian Costa, Michelle Byrne, Daniel Pissaloux, et al.
Neuroendocrinology|February 20, 2020
Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann SyndromeSara Barraud, Brigitte Delemer, Céline Poirsier-Violle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)Jean-Jacques Grob, Rene Gonzalez, Nicole Basset-Seguin, et al.
Archives of Dermatology|May 20, 2009
Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort studyPhilippe Bernard, Ziad Reguiai, Emmanuelle Tancrède-Bohin, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
ESMO Open|November 28, 2017
Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signatureJean-Jacques Grob, Laurent Mortier, Lionel D'Hondt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 24, 2025
Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomasDamien Sanogo, Romain Levard, Julie Cassecuel, et al.
Archives of Dermatology|September 19, 2012
Clinical and sociodemographic characteristics associated with thick melanomas. A population-based, case-case study in FranceFlorent Grange, Coralie Barbe, Francois Aubin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 29, 2026
Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS)Théo Erard, Gaelle Quéreux, Mona Amini-Adle, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|January 29, 2011
Sentinel lymph node biopsy or nodal observation in melanoma: a prospective study of patient choicesFlorent Grange, Eve Maubec, Coralie Barbe, et al.
JAMA Dermatology|August 16, 2013
Distinctive features of melanoma and its management in elderly patients: a population-based study in FranceDragos Ciocan, Coralie Barbe, Francois Aubin, et al.
The American Journal of Surgical Pathology|December 10, 2015
Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the ScalpSebastian Costa, Michelle Byrne, Daniel Pissaloux, et al.
Neuroendocrinology|February 20, 2020
Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann SyndromeSara Barraud, Brigitte Delemer, Céline Poirsier-Violle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2020
Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)Jean-Jacques Grob, Rene Gonzalez, Nicole Basset-Seguin, et al.
Archives of Dermatology|May 20, 2009
Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort studyPhilippe Bernard, Ziad Reguiai, Emmanuelle Tancrède-Bohin, et al.
Pageof 8